NME7 Antikörper (AA 1-150) (HRP)
Kurzübersicht für NME7 Antikörper (AA 1-150) (HRP) (ABIN7162047)
Target
Alle NME7 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1-150
-
Kreuzreaktivität
- Human
-
Aufreinigung
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Nucleoside diphosphate kinase 7 protein (1-150AA)
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C,-80 °C
-
Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- NME7 (Nucleoside Diphosphate Kinase (NME7))
-
Andere Bezeichnung
- NME7
-
Hintergrund
-
Background: Major role in the synthesis of nucleoside triphosphates other than ATP. The ATP gamma phosphate is transferred to the NDP beta phosphate via a ping-pong mechanism, using a phosphorylated active-site intermediate.
Aliases: MN23H7 antibody, NDK 7 antibody, NDK7_HUMAN antibody, NDP kinase 7 antibody, nm23 H7 antibody, nm23-H7 antibody, NME/NM23 family member 7 antibody, Nme7 antibody, Non metastatic cells 7 protein expressed in (nucleoside diphosphate kinase) antibody, Nucleoside diphosphate kinase 7 antibody
-
UniProt
- Q9Y5B8
Target
-